China NT Pharma and Hilong raise a combined $342 million

Investors respond well to the Hong Kong IPOs of China NT Pharma and Hilong, helping them to raise a total of $342 million.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES